FBXO28 and hepatocellular carcinoma: Patients with higher FBXO28 expression exhibit longer overall survival (OS) and relapse-free survival (RFS) time than those with lower expression via Kaplan–Meier survival analysis in HCC cohorts (www.kmplot.com) (Fig. 2B, C).